These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 31862132)

  • 1. Corrigendum to "Triptolide inhibits the migration and invasion of human prostate cancer cells via Caveolin-1/CD147/MMPs pathway" [Biomed. Pharmacother. 84 (2016) 1776-1782].
    Yuan S; Wang L; Chen X; Fan B; Yuan Q; Zhang H; Yang D; Wang S
    Biomed Pharmacother; 2020 Feb; 122():109782. PubMed ID: 31862132
    [No Abstract]   [Full Text] [Related]  

  • 2. Triptolide inhibits the migration and invasion of human prostate cancer cells via Caveolin-1/CD147/MMPs pathway.
    Yuan S; Wang L; Chen X; Fan B; Yuan Q; Zhang H; Yang D; Wang S
    Biomed Pharmacother; 2016 Dec; 84():1776-1782. PubMed ID: 27847199
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Corrigendum to "Tanshinone IIA inhibits cervix carcinoma stem cells migration and invasion via inhibiting YAP transcriptional activity" [Biomed. Pharmacother. 105 (2018) 758-765].
    Qin J; Shi H; Xu Y; Zhao F; Wang Q
    Biomed Pharmacother; 2019 Oct; 118():109107. PubMed ID: 31227337
    [No Abstract]   [Full Text] [Related]  

  • 4. Corrigendum to "Cryptotanshinone induces melanoma cancer cells apoptosis via ROS-mitochondrial apoptotic pathway and impairs cell migration and invasion" [Biomed. Pharmacother. 82 (2016) 319-326].
    Ye T; Zhu S; Zhu Y; Feng Q; He B; Xiong Y; Zhao L; Zhang Y; Yu L; Yang L
    Biomed Pharmacother; 2019 Dec; 120():109510. PubMed ID: 31635901
    [No Abstract]   [Full Text] [Related]  

  • 5. Corrigendum to "Huachansu capsule inhibits the proliferation of human gastric cancer cells via Akt/mTOR pathway" [Biomed. Pharmacother. 118 (2019) 109241].
    Ni T; Wang H; Li D; Tao L; Lv M; Jin F; Wang W; Feng J; Qian Y; Sunagawa M; Liu Y
    Biomed Pharmacother; 2020 Mar; 123():109823. PubMed ID: 31959384
    [No Abstract]   [Full Text] [Related]  

  • 6. 'Corrigendum to "Resveratrol inhibits proliferation, migration and invasion via Akt and ERK1/2 signaling pathways in renal carcinoma cells" [Biomed. Pharmacother. 98 (2018) 36-44]'.
    Zhao Y; Tang H; Zeng X; Ye D; Liu J
    Biomed Pharmacother; 2022 Sep; 153():113329. PubMed ID: 35760645
    [No Abstract]   [Full Text] [Related]  

  • 7. Corrigendum to "Study on the efficacy and mechanism of triptolide on treating TNF transgenic mice with rheumatoid arthritis" [Biomed. Pharmacother. 106 (2018) 813-820].
    Wang S; Zuo S; Liu Z; Ji X; Yao Z; Wang X
    Biomed Pharmacother; 2019 Mar; 111():1509. PubMed ID: 30413297
    [No Abstract]   [Full Text] [Related]  

  • 8. Corrigendum to "ZSCAN16 promotes proliferation, migration and invasion of bladder cancer via regulating NF-kB, AKT, mTOR, P38 and other genes" [Biomed. Pharmacother. 126 (2020) 110066].
    Li X; Shang D; Shen H; Song J; Hao G; Tian Y
    Biomed Pharmacother; 2020 Oct; 130():110858. PubMed ID: 33054976
    [No Abstract]   [Full Text] [Related]  

  • 9. Retraction notice to "Sinomenine inhibits proliferation, migration, invasion and promotes apoptosis of prostate cancer cells by regulation of miR-23a" [Biomed. Pharmacother. 112 (2019) 108592].
    Xu F; Li Q; Wang Z; Cao X
    Biomed Pharmacother; 2022 Apr; 148():112781. PubMed ID: 35272893
    [No Abstract]   [Full Text] [Related]  

  • 10. Corrigendum to "Saikosaponin A inhibits the activation of pancreatic stellate cells by suppressing autophagy and the NLRP3 inflammasome via the AMPK/mTOR pathway" [Biomed. Pharmacother. 128 (2020) 110216].
    Cui L; Li C; Zhuo Y; Yang L; Cui N; Li Y; Zhang S
    Biomed Pharmacother; 2020 Oct; 130():110685. PubMed ID: 32893050
    [No Abstract]   [Full Text] [Related]  

  • 11. Corrigendum to "Lobaplatin arrests cell cycle progression, induces apoptosis and impairs migration and invasion in B16-F10 melanoma cell line in vitro" [Biomed. Pharmacother. 69 (2015) 402-408].
    Yang F; Yu Y; Lei Q; Zeng A; Li Y; Xie Y; Ye T; Wei Y
    Biomed Pharmacother; 2019 Dec; 120():109511. PubMed ID: 31629561
    [No Abstract]   [Full Text] [Related]  

  • 12. Corrigendum to 'Rutaecarpine administration inhibits cancer cell growth in allogenic TRAMP-C1 prostate cancer mice correlating with immune balance in vivo' [Biomed. Pharmacother. 139 (2021) 111648].
    Yeh TH; Lin JY
    Biomed Pharmacother; 2021 Sep; 141():111751. PubMed ID: 34144859
    [No Abstract]   [Full Text] [Related]  

  • 13. Corrigendum to "Baohuoside-1 targeting mTOR inducing apoptsis to inhibit hepatocellular carcinoma proliferation, invasion and migration" [Biomed. Pharmacother. 128 (2020) 110366].
    Guo Y; Zhu H; Weng M; Chen B; Wang C; Sun L
    Biomed Pharmacother; 2020 Sep; 129():110394. PubMed ID: 32561180
    [No Abstract]   [Full Text] [Related]  

  • 14. Corrigendum to "Baohuoside-1 targeting mTOR inducing apoptsis to inhibit hepatocellular carcinoma proliferation, invasion and migration" [Biomed. Pharmacother. 2020 (128) 110366].
    Guo Y; Zhu H; Weng M; Chen B; Wang C; Sun L
    Biomed Pharmacother; 2020 Oct; 130():110631. PubMed ID: 32828598
    [No Abstract]   [Full Text] [Related]  

  • 15. Corrigendum to: "Network-pharmacology-based identification of caveolin-1 as a key target of Oldenlandia diffusa to suppress breast cancer metastasis" [Biomed. Pharmacother. 112 (2019) 108607].
    Yang B; Wang N; Wang S; Li X; Zheng Y; Li M; Song J; Zhang F; Mei W; Lin Y; Wang Z
    Biomed Pharmacother; 2022 Sep; 153():113294. PubMed ID: 35718649
    [No Abstract]   [Full Text] [Related]  

  • 16. Corrigendum to "Folate inhibits miR-27a-3p expression during cervical carcinoma progression and oncogenic activity in human cervical cancer cells" [Biomed. Pharmacother. 122 (2020) 109654].
    Wang Z; Wang W; Zhao W; Wang Z; Yang J; Wang W; Teng P; Su X; Li D; Zhang X; Wang H; Hao M
    Biomed Pharmacother; 2020 May; 125():109981. PubMed ID: 32067843
    [No Abstract]   [Full Text] [Related]  

  • 17. Corrigendum to "LINC01116 targets miR-520a-3p and affects IL6R to promote the proliferation and migration of osteosarcoma cells through the Jak-stat signaling pathway" [Biomed. Pharmacother. 107 (2018) 270-282].
    Zhang B; Yu L; Han N; Hu Z; Wang S; Ding L; Jiang J
    Biomed Pharmacother; 2019 Mar; 111():1508. PubMed ID: 30600120
    [No Abstract]   [Full Text] [Related]  

  • 18. Corrigendum to "MicroRNA-769-5p contributes to the proliferation, migration and invasion of hepatocellular carcinoma cells by attenuating RYBP" [Biomed. Pharmacother. 118 (2019) 109343].
    Xian Y; Wang L; Yao B; Yang W; Mo H; Zhang L; Tu K
    Biomed Pharmacother; 2022 Sep; 153():113448. PubMed ID: 35868955
    [No Abstract]   [Full Text] [Related]  

  • 19. Corrigendum to "Schisandrin A inhibits triple negative breast cancer cells by regulating Wnt/ER stress signaling pathway" [Biomed. Pharmacother. 115 (2019) 108922].
    Xu X; Rajamanicham V; Xu S; Liu Z; Yan T; Liang G; Guo G; Zhou H; Wang Y
    Biomed Pharmacother; 2022 May; 149():112865. PubMed ID: 35367116
    [No Abstract]   [Full Text] [Related]  

  • 20. Corrigendum to 'Metapristone suppresses non-small cell lung cancer proliferation and metastasis via modulating RAS/RAF/MEK/MAPK signaling pathway' [Biomed. Pharmacother. 90 (2017) 437-445].
    Zheng G; Shen Z; Chen H; Liu J; Jiang K; Fan L; Jia L; Shao J
    Biomed Pharmacother; 2018 Feb; 98():925-926. PubMed ID: 29421862
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.